Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy

Fig. 4

Binding diagram of eight representational molecule-target pairs. The left one in each group is the schematic drawing of virtual docking and the right is surface plasmon resonance (SPR) result. a NAD-dependent protein deacetylase sirtuin-1 (SIRT1) and baicalin. b 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and baicalin. c Tyrosine-protein kinase Janus kinase 3 (JAK3) and baicalin. d Hepatocyte nuclear factor 4-alpha (HNF4A) and baicalin. e NAD-dependent protein deacetylase sirtuin-1 (SIRT1) and wogonoside. f 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and wogonoside. g Tyrosine-protein kinase Janus kinase 3 (JAK3) and wogonoside. h Hepatocyte nuclear factor 4-alpha (HNF4A) and wogonoside

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us